Isnain, Merlyn S.
HRN: 16-99-22 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2022
CEFUROXIME 1.5GM (VIAL)
11/16/2022
11/16/2022
IV
1.5g
Now
Prim LTCS
Waiting Final Action
11/16/2022
CEFUROXIME 500MG (TAB)
11/16/2022
11/22/2022
ORAL
500mg
BID
S/P LTCS
Waiting Final Action